These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6148664)

  • 1. [Life expectancy of patients with cirrhosis].
    Eisenburg J
    Lebensversicher Med; 1984 Jul; 36(6):129-36. PubMed ID: 6148664
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prognostic factors for survival in cirrhosis].
    Ennaifer R; Ouakaa-Kchaou A; BelHadj N; Elloumi H; Gargouri D; Kochlef A; Kilani A; Romani M; Kharrat J; Ghorbel A
    Tunis Med; 2007 Dec; 85(12):1039-43. PubMed ID: 19170384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Survival and prognosis in hepatic cirrhosis. Statistical study of 319 cases and comparison of the data from the periods 1947-55 and 1959-67].
    Colucci CF; De Luca FP; Esposito R
    Minerva Med; 1971 May; 62(36):1841-57. PubMed ID: 5580496
    [No Abstract]   [Full Text] [Related]  

  • 4. [Etiology, complications and prognosis of liver cirrhosis in 917 patients. II. Causes of death and prognosis in liver cirrhosis].
    Epple A; Kühn HA; Leveringhaus M; Liehr H
    Lebensversicher Med; 1979 Sep; 31(5):117-22. PubMed ID: 40079
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical profile and prognosis of bacteremia in patients with cirrhosis based on the Child-Pugh classification].
    Monte Secades R; Casariego Vales E; Mateos Colino A; Rigueiro Veloso T; Alonso García P; Rodríguez Feijoo A; Corredoira Sánchez J
    Rev Clin Esp; 1999 Nov; 199(11):716-21. PubMed ID: 10638235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cirrhosis and renal failure: the influence of creatinine value on prognosis].
    Yaghi C; Sayegh R; Fayad N; Honein K; Bou Jaoude J; Khouri K
    J Med Liban; 2003; 51(1):15-23. PubMed ID: 15181956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinico-statistical observations in hepatic cirrhosis].
    Milani A; Marra L; Bellini V; Rossi L
    Recenti Prog Med; 1985 Mar; 76(3):130-4. PubMed ID: 4012015
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the prognosis of liver cirrhosis].
    Ruf-Bächtiger L
    Schweiz Med Wochenschr; 1967 Jan; 97(4):124-8 concl. PubMed ID: 6032301
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the prognosis of liver cirrhosis].
    Ruf-Bächtiger L
    Schweiz Med Wochenschr; 1967 Jan; 97(3):74-8 contd. PubMed ID: 6032295
    [No Abstract]   [Full Text] [Related]  

  • 10. Obesity in patients with cirrhosis of the liver.
    Juhl E; Quaade F
    Scand J Gastroenterol Suppl; 1970; 7():207-11. PubMed ID: 5460409
    [No Abstract]   [Full Text] [Related]  

  • 11. [Survival time of patients with liver cirrhosis].
    Brügel H
    Munch Med Wochenschr; 1967 Apr; 109(16):897-901. PubMed ID: 5631550
    [No Abstract]   [Full Text] [Related]  

  • 12. Open-heart surgery in patients with liver cirrhosis: indications, risk factors, and clinical outcomes.
    An Y; Xiao YB; Zhong QJ
    Eur Surg Res; 2007; 39(2):67-74. PubMed ID: 17283429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
    Tacke F; Fiedler K; von Depka M; Luedde T; Hecker H; Manns MP; Ganser A; Trautwein C
    Liver Int; 2006 Mar; 26(2):173-81. PubMed ID: 16448455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of short-term outcome of spontaneous bacterial peritonitis in Turkish cirrhotic patients.
    Soylu AR; Dökmeci G; Tezel A; Umit H; Amuca H; Akova M; Türe M; Bayraktar Y
    J Gastroenterol Hepatol; 2005 Apr; 20(4):657-60. PubMed ID: 15836724
    [No Abstract]   [Full Text] [Related]  

  • 15. [Should one treat with systemic adriamycin inoperable hepatocellular cancer in cirrhosis?].
    Ballet F; Barbare JC; Petit J; Poupon R; Darnis F
    Gastroenterol Clin Biol; 1982 Mar; 6(3):267-71. PubMed ID: 6284580
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mortality from infectious hepatitis, liver cirrhosis and acute and subacute necrosis (yellow atrophy) of the liver in Poland in 1959-1965. I].
    Magdzik W
    Przegl Epidemiol; 1968; 22(1):23-35. PubMed ID: 5669173
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical characteristics and outcome of patients with cirrhosis and refractory ascites.
    Moreau R; Delègue P; Pessione F; Hillaire S; Durand F; Lebrec D; Valla DC
    Liver Int; 2004 Oct; 24(5):457-64. PubMed ID: 15482343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reliability of death certification of cirrhosis.
    Duffy GJ; Dean G
    J Ir Med Assoc; 1971 Aug; 64(417):393-7. PubMed ID: 5562381
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular disease in cirrhosis--a point-prevalence study in relation to glucose tolerance.
    Marchesini G; Ronchi M; Forlani G; Bugianesi E; Bianchi G; Fabbri A; Zoli M; Melchionda N
    Am J Gastroenterol; 1999 Mar; 94(3):655-62. PubMed ID: 10086647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model for end-stage liver disease, model for end-stage liver disease-sodium and Child-Turcotte-Pugh scores over time for the prediction of complications of liver cirrhosis.
    Choi PC; Kim HJ; Choi WH; Park DI; Park JH; Cho YK; Sohn CI; Jeon WK; Kim BI
    Liver Int; 2009 Feb; 29(2):221-6. PubMed ID: 18544124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.